We unite the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in Merkel cell carcinoma (MCC) research through clinical trials not available everywhere.

Patients undergoing resection of Merkel cell carcinoma have improved distant metastasis-free survival with adjuvant pembrolizumab — but any benefits for overall survival remain to be seen.

In a prospective study of patients with stages I-III Merkel cell carcinoma (MCC), seropositivity for rising polyomavirus oncoprotein antibody titers conferred a 58% risk for recurrence at 12 months, ...

Please provide your email address to receive an email when new articles are posted on . 65.1% and 63.8% of Merkel cell carcinoma cases were attributed to ambient ultraviolet radiation exposure and ...

Please provide your email address to receive an email when new articles are posted on . The 5-year survival rate of patients with Merkel cell carcinoma was higher in Medicaid expansion vs.

A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer, according to research led by University of Arizona Cancer Center researchers ...

Recurrence-free survival was numerically higher with adjuvant pembrolizumab, but difference was not significant. HealthDay News — For patients with resected Merkel cell carcinoma (MCC), adjuvant ...

Understanding the stages of Merkel cell carcinoma (MCC) helps you and your physician know how far the cancer has grown or spread. These stages also guide decisions about the treatment options your ...

Megha Padi, PhD, is a member of the University of Arizona Cancer Center and an assistant professor at the U of A College of Science. Merkel cell carcinoma is a rare but fast-growing neuroendocrine ...

The detection of metastases in Merkel cell carcinoma (MCC) requires additional testing, such as pancytokeratin (panCK) or CK20, with no guarantee of success. Recent findings have identified ...

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer, by targeting the protein essential to tumor cell growth and by adding a key signal to ...